Average Co-Inventor Count = 5.96
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (29 from 822 patents)
2. Array Biopharma Inc. (14 from 329 patents)
3. Merck + Co., Inc. (9 from 4,770 patents)
4. The Walter and Eliza Hall Institute of Medical Research (3 from 80 patents)
5. Genentech, Inc. (2 from 3,221 patents)
6. Ventirx Pharmaceuticals, Inc. (2 from 10 patents)
7. Abbott Laboratories Corporation (1 from 4,177 patents)
8. Abbott Gmbh & Co Kg (1 from 139 patents)
9. Abbvie Manufacturing Management Unlimited Company (1 patent)
53 patents:
1. 11964990 - 1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors
2. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
3. 11786519 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
4. 11633497 - Anti-c-Met antibody drug conjugates
5. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use
6. 9877958 - Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
7. 9844547 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
8. 9556139 - 6-substituted phenoxychroman carboxylic acid derivatives
9. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10. 9266877 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11. 9242964 - Substituted benzoazepines as toll-like receptor modulators
12. 9227963 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
13. 9193723 - NAMPT inhibitors
14. 9187472 - NAMPT inhibitors
15. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases